Question follow-through · 7126
Prescriptions: Fees and Charges
To ask the Secretary of State for Health and Social Care, if he will commit to a review of the prescription charge exemption list to reflect the changing nature of many long-term conditions including cystic fibrosis.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 5 Jun 2026
- Target answer date
- 9 Jun 2026
- Answer
- 15 Jun 2026 · 10 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Gynaecology · 8 Jun 2026
- Gynaecology: Waiting Lists · 8 Jun 2026
- Women's Health Hubs · 8 Jun 2026
- Gynaecology: Disadvantaged · 8 Jun 2026
- Gynaecology · 8 Jun 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
5 Jun 2026
Question tabled
To ask the Secretary of State for Health and Social Care, if he will commit to a review of the prescription charge exemption list to reflect the changing nature of many long-term conditions including cystic fibrosis.
9 Jun 2026
Target answer date
Date supplied by the official written-questions record.
15 Jun 2026
Answer published
The Government currently has no plans to review or amend the list of medical conditions that entitle someone to apply for a medical exemption certificate.
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Gynaecology
8 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of consultant obstetricians and gynaecologists to support delivery of the 2026 Renewed Women’s Health Strategy for England.
Gynaecology: Waiting Lists
8 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the 2026 Renewed Women’s Health Strategy for England on waiting times for gynaecology services.
Women's Health Hubs
8 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of women’s health hubs on delivering the objectives of the 2026 Renewed Women’s Health Strategy for England.
Gynaecology: Disadvantaged
8 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to improve access to specialist women’s health services for women in deprived areas.
Gynaecology
8 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether he plans to publish annual progress reports on the implementation of the 2026 Renewed Women’s Health Strategy for England.
Diethylstilbestrol: Medical Records
25 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that individuals known to have been exposed to diethylstilbestrol (DES) in utero have that exposure recorded on their own NHS medical records, rather t
Diethylstilbestrol: Side Effects
25 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether he plans to issue guidance to NHS England on the provision of additional cervical and vaginal cancer surveillance for women exposed in utero to diethylstilbestrol (DES), beyond HPV primary
Diethylstilbestrol: Health Education
25 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that Government policy and NHS guidance relating to diethylstilbestrol (DES) exposure are communicated to and accessible by all people exposed to DES i
Neurology: Drugs
29 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether the Care Quality Commission's assessment framework requires providers to evidence medicines safety checks for psychiatric history, psychotropic medication use and previous psychiatric adver
Neurology: Drugs
29 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether NHS England's neurology service specifications require providers to include structured mental health and medication safety fields in headache referral, assessment and prescribing templates.
Migraines: Drugs
29 Jun 2026 · To ask the Secretary of State for Health and Social Care, what mechanism exists for psychiatric adverse drug reaction signals, including Yellow Card reports and Prevention of Future Deaths reports, to be considered in national migraine prescribing guidanc
Psychotherapy: Regulation
6 Jul 2026 · To ask the Secretary of State for Health and Social Care, what assessment the Department has made of the potential impact of psychotherapy and counselling remaining outside statutory regulation on public protection, in the context that other psychological